TG THERAPEUTICS, INC. Accounts Payable and Accrued Liabilities, Current
TG THERAPEUTICS, INC. (TGTX) had Accounts Payable and Accrued Liabilities, Current of $213.69 million as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent · last filed 2026-08-05
- 2026-06-30: Accounts Payable and Accrued Liabilities, Current $213.69M.
- 2026-03-31: Accounts Payable and Accrued Liabilities, Current $148.84M.
- 2025-12-31: Accounts Payable and Accrued Liabilities, Current $107.51M.
- 2025-09-30: Accounts Payable and Accrued Liabilities, Current $112.34M.
| Period end | Accounts Payable and Accrued Liabilities, Current | Accounts Payable and Accrued Liabilities, Current as first filed |
|---|---|---|
| 2026-06-30 | $213.69M 10-Q · filed 2026-08-05 | |
| 2026-03-31 | $148.84M 10-Q · filed 2026-05-06 | |
| 2025-12-31 | $107.51M 10-Q · filed 2026-08-05 | |
| 2025-09-30 | $112.34M 10-Q · filed 2025-11-05 | |
| 2025-06-30 | $134.02M 10-Q · filed 2025-08-08 | |
| 2025-03-31 | $133.93M 10-Q · filed 2025-05-09 | |
| 2024-12-31 | $58.30M 10-K · filed 2026-02-27 | |
| 2024-09-30 | $101.41M 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $93.47M 10-Q · filed 2024-08-09 | |
| 2024-03-31 | $87.27M 10-Q · filed 2024-05-06 | |
| 2023-12-31 | $38.47M 10-K · filed 2025-03-03 | |
| 2023-09-30 | $39.74M 10-Q · filed 2023-11-06 | |
| 2023-06-30 | $62.95M 10-Q · filed 2023-08-04 | |
| 2023-03-31 | $57.09M 10-Q · filed 2023-05-08 | |
| 2022-12-31 | $42.02M 10-K · filed 2024-02-29 | |
| 2022-09-30 | $29.73M 10-Q · filed 2022-11-09 | |
| 2022-06-30 | $37.22M 10-Q · filed 2022-08-09 | |
| 2022-03-31 | $49.67M 10-Q · filed 2022-05-10 | |
| 2021-12-31 | $51.29M 10-K · filed 2023-03-01 | |
| 2021-09-30 | $44.70M 10-Q · filed 2021-11-08 | |
| 2021-06-30 | $40.23M 10-Q · filed 2021-08-06 | |
| 2021-03-31 | $42.84M 10-Q · filed 2021-05-10 | |
| 2020-12-31 | $37.01M 10-K · filed 2022-03-01 | |
| 2020-09-30 | $34.66M 10-Q · filed 2020-11-09 | |
| 2020-06-30 | $29.67M 10-Q · filed 2020-08-10 | |
| 2020-03-31 | $30.90M 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $30.04M 10-K · filed 2021-03-01 | |
| 2019-09-30 | $31.78M 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $31.50M 10-Q · filed 2019-08-09 | |
| 2019-03-31 | $40.20M 10-Q · filed 2019-05-10 | |
| 2018-12-31 | $36.38M 10-K · filed 2020-03-02 | |
| 2018-09-30 | $37.92M 10-Q · filed 2018-11-09 | |
| 2018-06-30 | $35.39M 10-Q · filed 2018-08-09 | |
| 2018-03-31 | $32.51M 10-Q · filed 2018-05-10 | |
| 2017-12-31 | $25.88M 10-K · filed 2019-03-01 | $25.88M 10-K · filed 2018-03-15 |
| 2017-09-30 | $18.18M 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $19.56M 10-Q · filed 2017-08-09 | |
| 2017-03-31 | $18.92M 10-Q · filed 2017-05-10 | |
| 2016-12-31 | $15.27M 10-K · filed 2018-03-15 | |
| 2016-09-30 | $15.55M 10-Q · filed 2016-11-09 | |
| 2016-06-30 | $13.08M 10-Q · filed 2016-08-09 | |
| 2016-03-31 | $8.14M 10-Q · filed 2016-05-10 | |
| 2015-12-31 | $9.35M 10-K · filed 2017-03-16 | |
| 2015-09-30 | $8.58M 10-Q · filed 2015-11-09 | |
| 2015-06-30 | $8.25M 10-Q · filed 2015-08-10 | |
| 2015-03-31 | $8.88M 10-Q · filed 2015-05-11 | |
| 2014-12-31 | $3.99M 10-K · filed 2016-03-15 | |
| 2014-09-30 | $7.97M 10-Q · filed 2014-11-14 | |
| 2014-06-30 | $1.90M 10-Q · filed 2014-07-24 | |
| 2014-03-31 | $1.64M 10-Q · filed 2014-05-14 | |
| 2013-12-31 | $4.76M 10-K · filed 2015-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |